ribavirin has been researched along with Pulmonary Disease, Chronic Obstructive in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Baker, SJ; Billiard, J; Chandrasekaran, V; Dennison, J; Dumont, EF; Georgiou, A; Gillies, A; Harrell, AW; Hopchet, N; Ioannou, C; Lahiry, A; Oliver, AJ; Starbuck, DC; van den Berg, F; Yang, S; Young, GC | 1 |
Force, SD; Foster, M; Gal, AA; Lawrence, EC; Lyon, GM; Mitchell, PO; Naik, PM; Neujahr, DC; Pelaez, A; Ramirez, AM | 1 |
Atluri, D; Iduru, S; Mullen, K; Veluru, C | 1 |
Falsey, AR | 1 |
Crespo, M; Husain, S; Ismailjee, SB; Kwak, EJ; McCurry, KR; Paterson, DL; Pilewski, JM; Raza, K; Rinaldo, CR; Sanghavi, S; Studer, SM | 1 |
1 review(s) available for ribavirin and Pulmonary Disease, Chronic Obstructive
Article | Year |
---|---|
Respiratory syncytial virus infection in adults.
Topics: Aged; Aged, 80 and over; Antiviral Agents; Asthma; Communicable Disease Control; Communicable Diseases; Cross Infection; Homes for the Aged; Humans; Middle Aged; Nursing Homes; Pneumonia, Viral; Pulmonary Disease, Chronic Obstructive; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus Vaccines; Respiratory Syncytial Virus, Human; Ribavirin | 2007 |
1 trial(s) available for ribavirin and Pulmonary Disease, Chronic Obstructive
Article | Year |
---|---|
A Novel Inhaled Dry-Powder Formulation of Ribavirin Allows for Efficient Lung Delivery in Healthy Participants and Those with Chronic Obstructive Pulmonary Disease in a Phase 1 Study.
Topics: Administration, Inhalation; Adult; Aged; Antiviral Agents; Double-Blind Method; Drug Delivery Systems; Dry Powder Inhalers; Female; Healthy Volunteers; Humans; Lung; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Respiratory Mucosa; Ribavirin; Young Adult | 2020 |
3 other study(ies) available for ribavirin and Pulmonary Disease, Chronic Obstructive
Article | Year |
---|---|
Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Aged; Antiviral Agents; Bronchoalveolar Lavage Fluid; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Infusions, Intravenous; Lung Transplantation; Male; Methylprednisolone Hemisuccinate; Middle Aged; Postoperative Complications; Pulmonary Disease, Chronic Obstructive; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Sarcoidosis; Time Factors | 2009 |
A levitating tattoo in a hepatitis C patient on treatment.
Topics: Antiviral Agents; Biopsy, Needle; Drug Therapy, Combination; Follow-Up Studies; Hepatitis C, Chronic; Humans; Immunohistochemistry; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Pulmonary Disease, Chronic Obstructive; Recombinant Proteins; Ribavirin; Risk Assessment; Sarcoidosis; Skin Diseases; Steroids; Tattooing; Treatment Outcome | 2010 |
Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin.
Topics: Antiviral Agents; Biopsy; Bronchoscopy; Diagnosis, Differential; DNA, Viral; Female; Follow-Up Studies; Humans; Lung; Lung Transplantation; Metapneumovirus; Middle Aged; Paramyxoviridae Infections; Pneumonia, Viral; Postoperative Complications; Pulmonary Disease, Chronic Obstructive; Ribavirin | 2007 |